Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microplasmin for Vitreomacular Traction
NCT00435539Phase 2Completed
- Sponsor
- Oxurion
- Start
- Feb 2007
- Primary completion
- Jan 2009
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of ocriplasmin in vitreomacular traction (VMT), sponsored by Oxurion. Started Feb 2007; status: completed.
02
Drugs
ocriplasmin
03
Conditions
vitreomacular traction (VMT)
Beyond the preview
Go deeper on NCT00435539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435539.